Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of January 20th – 26th, 2020.

Without further ado, let’s get started.

10. 4 North American Pot Stocks With New ‘BUY’ Ratings and Price Targets

New Ratings Released By Echelon Wealth Partners, Beacon Securities, M Partners and Clarus Securities

It’s been a busy week in the cannabis sector as four different analysts have initiated coverage or released research updates on 2 U.S. Multi-State Operators (MSO) as well as 2 Canadian Licensed Producers (LP). All four Cannabis Stocks received ‘Buy’ ratings and bullish price targets.

READ FULL NEW RATINGS ARTICLE

9. TSX and S&P Launch New Cannabis Indices, Here’s the Full List of Constituents From Each Index

Let’s Take a Look at the Constituents That Make Up of Both Cannabis Indices

The new cannabis indices released by Dow Jones Indices and the TMX Group, which owns and operates the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) features a mix of Canadian and international Pot Stocks. Here is the full list of constituents that make up both cannabis indices.

READ FULL CANNABIS INDICES ARTICLE

8. Dan Bilzerian’s Ignite International Expands Product Line Forming New IGNITE Beverages Division

Ignite to Launch a Variety of Ready-to-Drink Beverages Featuring a Branded Alkaline PH9 Water

Ignite International Brands BILZ BILZF 2L announced that the company is expanding its product offerings with the formation of a new business division called IGNITE Beverages. BILZ stock soared over 12% the day of the beverage announcement which may have catalyzed a reversal in the stock.

READ FULL IGNITE BEVERAGES ARTICLE

7. Analyzing Medmen CEO Adam Bierman’s Response To Market Rumours

For Those Focused on the Cannabis Sector, You’re Likely Aware of the Recent Drama with MedMen

Multiple sources have indicated that suppliers of MedMen MMEN MMNNF 0JS have not been paid and that the company is currently renegotiating with vendors to decrease payables. Social media has been bustling to get to the bottom of things with one media firm publishing a Q&A with MedMen CEO Adam Bierman to discuss the rumours.

READ FULL MEDMEN ARTICLE

6. Is Aurora Cannabis the Titanic of Marijuana Stocks?

Some Think ACB is Headed for an Epic Disaster, Here’s Where They’re Right and Where They’re Wrong

Comparing certain Pot Stocks to a ship probably isn’t the best analogy. However, I couldn’t help thinking of the Titanic after seeing some of the headlines over the last couple of months about Aurora Cannabis ACB ACB (FRA: 21P). For example, in December an analyst placed a $0 price target on ACB stock. Investors couldn’t be blamed if they have a sinking feeling. But is Aurora Cannabis really the Titanic of Marijuana Stocks?

READ FULL AURORA CANNABIS ARTICLE

5. Which Cannabis ETF is the Best?

Wondering How to Play the Marijuana Sector? Try an ETF

Wondering which Cannabis ETF is the best? This analyst says choose Evolve Marijuana ETF SEED over Horizons Marijuana Life Sciences Index ETF HMMJ.

READ FULL CANNABIS ETFS ARTICLE

4. Aphria Receives EU GMP Certification, New Analyst Initiates Coverage, Places Bullish Price Target on APHA

Aphria Can Now Sell Medical Cannabis Throughout the EU with 1st Shipments to Germany Expected in Q4

Aphria APHA APHA (FRA: 10E) announced that the company has secured its European Union Good Manufacturing Practices certification also known as EU GMP certification for its subsidiary, ARA – Avanti Rx Analytics. APHA’s bullish stock chart is primed for a breakout after Alliance Global issued a new Buy rating and price target.

READ FULL APHRIA ARTICLE

3. Red White & Bloom Closes USD $50 Million Non-Dilutive Financing

No Warrants or Conversion Equity Rights Were Connected to RWB’s Financing

Red White & Bloom (RWB) closed on its new debt facility with a single institution with $50 million funded to RWB on the closing date. Prior to this investment, the company had raised over USD $90 million to fund its investments and operations in Michigan, Massachusetts and Illinois.

READ FULL RWB ARTICLE

2. American Cannabis Stocks Are Working Their Way to Wall Street

7 Years Ago There Were Very Few Publicly Traded Cannabis Companies, None of Them on Major Exchanges

Today, more than a dozen Cannabis Stocks trade on major exchanges, but few of them are operating in the United States. Instead, the vast majority of the Pot Stocks on the NYSE or NASDAQ operate in Canada, where cannabis is federally legal, though this is starting to change.

READ FULL US CANNABIS STOCKS ARTICLE

1. Aphria Secures 2nd EU GMP Certification, APHA Stock Surges 8% Confirming Breakout and Trend Reversal

Aphria Announces Back to Back EU GMP Certifications, This Time for Aphria One

Aphria APHA APHA (FRA: 10E) announced that the company has received a second EU GMP certification, this time for its Aphria One facility in Leamington, Ontario. This news served as the catalyst for APHA’s bullish technical breakout.

Image Sourced from Pixabay